1. Home
  2. RAPT vs BIT Comparison

RAPT vs BIT Comparison

Compare RAPT & BIT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RAPT
  • BIT
  • Stock Information
  • Founded
  • RAPT 2015
  • BIT 2013
  • Country
  • RAPT United States
  • BIT United States
  • Employees
  • RAPT N/A
  • BIT N/A
  • Industry
  • RAPT Biotechnology: Pharmaceutical Preparations
  • BIT Trusts Except Educational Religious and Charitable
  • Sector
  • RAPT Health Care
  • BIT Finance
  • Exchange
  • RAPT Nasdaq
  • BIT Nasdaq
  • Market Cap
  • RAPT 498.4M
  • BIT 573.0M
  • IPO Year
  • RAPT 2019
  • BIT N/A
  • Fundamental
  • Price
  • RAPT $29.86
  • BIT $13.24
  • Analyst Decision
  • RAPT Strong Buy
  • BIT
  • Analyst Count
  • RAPT 8
  • BIT 0
  • Target Price
  • RAPT $46.75
  • BIT N/A
  • AVG Volume (30 Days)
  • RAPT 614.9K
  • BIT 92.4K
  • Earning Date
  • RAPT 11-11-2025
  • BIT 01-01-0001
  • Dividend Yield
  • RAPT N/A
  • BIT 9.36%
  • EPS Growth
  • RAPT N/A
  • BIT N/A
  • EPS
  • RAPT N/A
  • BIT N/A
  • Revenue
  • RAPT N/A
  • BIT N/A
  • Revenue This Year
  • RAPT N/A
  • BIT N/A
  • Revenue Next Year
  • RAPT N/A
  • BIT N/A
  • P/E Ratio
  • RAPT N/A
  • BIT N/A
  • Revenue Growth
  • RAPT N/A
  • BIT N/A
  • 52 Week Low
  • RAPT $5.67
  • BIT $13.65
  • 52 Week High
  • RAPT $42.39
  • BIT $15.97
  • Technical
  • Relative Strength Index (RSI)
  • RAPT 61.81
  • BIT 41.80
  • Support Level
  • RAPT $25.50
  • BIT $13.02
  • Resistance Level
  • RAPT $42.39
  • BIT $13.46
  • Average True Range (ATR)
  • RAPT 3.91
  • BIT 0.12
  • MACD
  • RAPT -0.18
  • BIT 0.01
  • Stochastic Oscillator
  • RAPT 30.92
  • BIT 48.79

About RAPT RAPT Therapeutics Inc.

RAPT Therapeutics Inc is a clinical-stage immunology-based biopharmaceutical company. It is focused on discovering, developing, and commercializing oral small-molecule therapies for patients with some unmet needs in oncology and inflammatory diseases. The company pipeline products include FLX475, designed to selectively inhibit the migration of immunosuppressive regulatory T cells into tumors; and RPT193, designed to selectively inhibit the migration of type 2 T helper cells into inflamed tissues.

About BIT BlackRock Multi-Sector Income Trust of Beneficial Interest

BlackRock Multi-Sector Income Trust is a closed-end investment management company. It invests on behalf of its clients. The fund's primary investment objective is to provide a high level of current income, with a secondary objective of capital appreciation. The company seeks to achieve its investment objectives by investing, under normal market conditions, a majority of its assets in loan and debt instruments and other investments with similar economic characteristics. Its portfolio consists of Corporate Bonds, Asset-Backed Securities, Preferred Securities, and others.

Share on Social Networks: